CompletedNCT00271219
Methadone or buprenorphine treatment during pregnancy
About this title
Read the official source — NCT00271219Medication studyAges 18–41Multiple countriesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 41 years.
- Listed locations
- Baltimore and 7 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJuly 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 175
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada, Austria
- Age range
- From 18 Years to 41 Years
- Official registry ID
- NCT00271219
- Official title
Show the full official title
Maternal Opioid Treatment: Human Experimental Research
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore, United States · Detroit, United States · Philadelphia, United States
5 more locations
- Providence, United States
- Nashville, United States
- Burlington, United States
- Vienna, Austria
- Toronto, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Did this study involve medication?
Yes. The study involved medication, including Methadone and Buprenorphine.
Who was this study for?
Listed age limits: 18 years to 41 years.
